logo
Share SHARE
FONT-SIZE Plus   Neg

Santarus, Pharming Present Retrospective Analyses Of Data From RHUCIN Studies

Santarus, Inc. (SNTS) and Pharming Group NV (PHGUF.PK) said that retrospective analyses of integrated efficacy data and immuno-safety data were presented in two oral presentations at the 2011 Biennial Meeting of the World Allergy Congress in Cancun, Mexico on December 6, 2011.

According to the company, the data analyzed are from placebo-controlled and open-label clinical studies conducted with the investigational drug RHUCIN in patients with hereditary angioedema, or HAE.

The first oral presentation was titled Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks. This integrated efficacy dataset included 155 HAE patients treated for 424 angioedema attacks with 100 U/kg, 50 U/kg and 2100 U of RHUCIN, including patients treated for repeated attacks. Median time to the primary endpoint of onset of symptom relief for attacks treated with 100 U/kg, 50 U/kg and 2100 U of RHUCIN were 66, 60 and 61 minutes, respectively, compared with 495 minutes in the placebo-treated group.

The second oral presentation was titled Immuno-safety of Recombinant Human C1 Inhibitor in Patients with Hereditary Angioedema: An Integrated Analysis. Data from this presentation were previously discussed, the companies noted.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Walt Disney Co. has threatened to pull its programming from cable distributor Altice USA Inc. if the two companies are unable to reach a new deal before the end of September. The current contract between the two companies expires at the end of this month. Jaguar Land Rover, Britain's biggest car maker, is eyeing potential acquisitions of international automakers, Bloomberg reported Monday, citing people with knowledge of the matter. Jaguar Land Rover, owned by India's Tata Motors Ltd., has reportedly been holding internal discussion on acquiring other brands in order to diversify its range of vehicles. Target Corp. said Monday that it plans to raise minimum hourly wage for all its workers to $11 in October, marking its third wage increase in three years. The discount-store operator also said it is committed to increasing the minimum hourly wage to $15 by the end of 2020.
comments powered by Disqus
Follow RTT